Vimarsana
Biggest News Aggregation in the World

Page 7 - Data Coordinating Center News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Data Coordinating Center. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Data Coordinating Center Today - Breaking & Trending Today

CMU CompBio Researchers Take Leading Roles in NIH SenNet Program - Vimarsana News

CMU CompBio Researchers Take Leading Roles in NIH SenNet Program

$125 million research initiative aims to study senescent cells, develop treatments for age-related diseases Carnegie Mellon University’s Computational

NIH launches program to map a rare type of non-dividing cells implicated in human health and disease - Vimarsana News

NIH launches program to map a rare type of non-dividing cells implicated in human health and disease

Senescent cells are a rare type of cells that play both positive and negative roles in biological processes.

Source: nih.gov
NIH launches program to map rare type of non-dividing cells implicated in human health and disease - Vimarsana News

NIH launches program to map rare type of non-dividing cells implicated in human health and disease

The National Institutes of Health has launched a program to study a rare type of cells, called “senescent” cells, that play both positive and negative

Urine test for detecting chronic kidney disease is not used enough in high-risk groups, study suggests - Vimarsana News

Urine test for detecting chronic kidney disease is not used enough in high-risk groups, study suggests

Despite their higher risk of chronic kidney disease, people with hypertension or diabetes usually are not given a simple test for protein in the urine to screen for this potentially deadly disorder, according to a study led by researchers at Johns Hopkins Bloomberg School of Public Health.

VUMC to lead national study to treat severe COVID complications - Vimarsana News

VUMC to lead national study to treat severe COVID complications

by Bill Snyder The Vanderbilt Institute for Clinical and Translational Research (VICTR) has been awarded a major federal grant to lead a national trial of treatments targeting the Renin Angiotensin Aldosterone System (RAAS) in patients hospitalized with COVID-19. Comprised of the hormones renin, angiotensin and aldosterone, RAAS is essential for the regulation of blood pressure and fluid balance. SARS-CoV-2, the virus that causes COVID-19, can disrupt this system, resulting in life-threatening complications, including pulmonary edema, thromboembolic complications and severe cardiac injury. Se...